Atlas Trials

MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis

Clinical trial NCT01497223 · COMPLETED

Trial details

NCT number
NCT01497223
Sponsor
MethylGene Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vulvovaginal Candidiasis
Start date
2011-12-01
Primary completion
2013-04-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.